Inside Roche Diagnostics’ Global Data and AI Portfolio Playbook

 

By 2027, Garner expects 80% of data and analytics leaders to recalibrate their Al value expectations. The companies that emerge stronger will not have the largest model libraries. Take a working playbook from one of the world’s largest life sciences companies. 

 

Roche Diagnostics centralized 300+ AI, data, and reporting assets into a single governed portfolio, giving teams 100% visibility across initiatives while standardizing more than 3 enterprise value streams. In this playbook, Head of Data Alexey Belichenko shares how Roche built a scalable data and AI operating model that aligns business, IT, and governance teams without slowing innovation.

 

The result is a more transparent, accountable approach to AI investment, built to move beyond experimentation and drive enterprise-wide impact.

 

Download here